Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Cairo University: Clinical Trials & FDA Approval Profile

Cairo University (Global / Institutional) sponsors 214 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 44 active protocols (18 recruiting now), 76 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)0.5%
Median Closed Enrollment vs National (145 pts)60 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Cairo University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)214
Active Pipeline (Recruiting Now)44 (18)
Completed vs Stopped Early76 / 1 (0.5%)
Median Closed Actual Enrollment60 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Explore interactive annual charts and M&A subsidiary rollups in the Cairo University Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI